Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

17 Feb 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38368440
DOI: 10.1038/s41375-024-02180-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimensPMID 38368440Read ↗

Germline DDX41 mutations define a significant entity within adult MDS/AML patientsSemantic proximity Read ↗

AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcomeSemantic proximity Read ↗

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasmsSemantic proximity Read ↗

Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.Semantic proximity Read ↗

The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.Semantic proximity Read ↗

Germline DDX41 Variants: Current Understanding and Future Directions.Semantic proximity Read ↗

Current Understanding of DDX41 Mutations in Myeloid NeoplasmsSemantic proximity Read ↗

Clinicopathological and prognostic significance of DDX41 mutation in myeloid neoplasms: a systematic review and meta-analysis.Semantic proximity Read ↗

Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDSSemantic proximity Read ↗

Next‐generation sequencing reveals the presence of DDX41 mutations in acute lymphoblastic leukemia and aplastic anemiaSemantic proximity Read ↗

Genetic features and clinical outcomes of patients with isolated and comutatedDDX41-mutated myeloid neoplasmsSemantic proximity Read ↗

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.